Ejvind Mørtz | Chief Scientific Officer and Co-Founder
Alphalyse

Ejvind Mørtz is a leading figure in proteomics and mass spectrometry analysis with more than 30 years of experience in biotechnology and protein biologics development. He holds a PhD in Protein Chemistry and Molecular Biology from the University of Southern Denmark. He has specialized in developing innovative protein analysis methods for chemistry, manufacturing, and control (CMC) development of protein biologics and complex products like gene therapies. Ejvind published his first article on protein identification using mass spectrometry in 1994 and has since co-authored close to 50 scientific articles on host cell proteins and mass spectrometry (LC-MS) analysis. His research has earned more than 3,200 citations in academic literature and has been instrumental in shaping best practices for protein analysis by LC-MS, now recommended in the US Pharmacopeia General Chapter <1132.1> for improving the quality and safety of biologics manufacturing. As an expert in the field, Ejvind has been invited to speak at numerous industry conferences. His contributions include talks at the BEBPA HCP Conference (2016, 2019, 2020, 2022, and 2023), the Bioprocessing Summit (2019), CASSS (2018), and many others.